Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 19110700)

1.

West Nile virus seroconversion in penguins after vaccination with a killed virus vaccine or a DNA vaccine.

Davis MR, Langan JN, Johnson YJ, Ritchie BW, Van Bonn W.

J Zoo Wildl Med. 2008 Dec;39(4):582-9.

PMID:
19110700
2.

Antibody response of five bird species after vaccination with a killed West Nile virus vaccine.

Okeson DM, Llizo SY, Miller CL, Glaser AL.

J Zoo Wildl Med. 2007 Jun;38(2):240-4.

PMID:
17679507
3.

Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).

Wolf TM, Gandolf AR, Dooley JL, Atkinson MW, Wolfe BA.

J Zoo Wildl Med. 2008 Dec;39(4):537-41.

PMID:
19110693
4.

Pathogenicity of West Nile virus and response to vaccination in sandhill cranes (Grus canadensis) using a killed vaccine.

Olsen GH, Miller KJ, Docherty DE, Bochsler VS, Sileo L.

J Zoo Wildl Med. 2009 Jun;40(2):263-71.

PMID:
19569472
5.

Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).

Redig PT, Tully TN, Ritchie BW, Roy AF, Baudena MA, Chang GJ.

Am J Vet Res. 2011 Aug;72(8):1065-70. doi: 10.2460/ajvr.72.8.1065.

PMID:
21801064
6.

Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.

Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP.

Equine Vet J. 2007 Nov;39(6):491-7.

PMID:
18065305
7.

Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.

Long MT, Gibbs EP, Mellencamp MW, Zhang S, Barnett DC, Seino KK, Beachboard SE, Humphrey PP.

Equine Vet J. 2007 Nov;39(6):486-90.

PMID:
18065304
8.

Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis).

Wheeler SS, Langevin S, Woods L, Carroll BD, Vickers W, Morrison SA, Chang GJ, Reisen WK, Boyce WM.

Vector Borne Zoonotic Dis. 2011 Aug;11(8):1069-80. doi: 10.1089/vbz.2010.0173. Epub 2011 Mar 25.

9.

Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.

Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J.

Vaccine. 2007 Nov 28;25(49):8338-45. Epub 2007 Oct 15.

PMID:
17977629
11.

Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).

Escribano-Romero E, Gamino V, Merino-Ramos T, Blázquez AB, Martín-Acebes MA, de Oya NJ, Gutiérrez-Guzmán AV, Escribano JM, Höfle U, Saiz JC.

Vaccine. 2013 Sep 23;31(41):4523-7. doi: 10.1016/j.vaccine.2013.07.071. Epub 2013 Aug 6.

PMID:
23933372
12.

Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.

Chang GJ, Davis BS, Stringfield C, Lutz C.

Vaccine. 2007 Mar 8;25(12):2325-30. Epub 2006 Dec 5.

PMID:
17224209
13.

Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.

De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, Sinigaglia A, Barzon L, Roels S, Lisziewicz J, Lorincz O, Sanders NN.

PLoS One. 2014 Feb 4;9(2):e87837. doi: 10.1371/journal.pone.0087837. eCollection 2014.

14.

A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.

Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S.

Vaccine. 2011 Aug 26;29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116. Epub 2011 May 17.

PMID:
21596075
15.

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.

El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V.

Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):230-9. doi: 10.1016/j.vetimm.2008.02.002. Epub 2008 Feb 16.

PMID:
18372050
16.

Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.

Venter M, van Vuren PJ, Mentoor J, Paweska J, Williams J.

Vaccine. 2013 Aug 20;31(37):3856-62. doi: 10.1016/j.vaccine.2013.06.059. Epub 2013 Jun 29.

PMID:
23820079
17.
18.

Baboon model for West Nile virus infection and vaccine evaluation.

Wolf RF, Papin JF, Hines-Boykin R, Chavez-Suarez M, White GL, Sakalian M, Dittmer DP.

Virology. 2006 Nov 10;355(1):44-51. Epub 2006 Aug 10.

19.

Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.

Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA.

Clin Vaccine Immunol. 2007 Nov;14(11):1465-71. Epub 2007 Aug 8.

20.

Limited efficacy of West Nile virus vaccines in large falcons (Falco spp.).

Angenvoort J, Fischer D, Fast C, Ziegler U, Eiden M, de la Fuente JG, Lierz M, Groschup MH.

Vet Res. 2014 Apr 7;45:41. doi: 10.1186/1297-9716-45-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk